Clinical predictor of pre-or minimally invasive pulmonary adenocarcinoma: Possibility of sub-classification of clinical T1a

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 2, 2014, Pages 256-261

  Sawabata, Noriyoshi ^a   Kanzaki, Ryu ^a   Sakamoto, Tetsuki ^a   Kusumoto, Hidenori ^a   Kimura, Toru ^a   Nojiri, Takashi ^a   Kawamura, Tomohiro ^a   Susaki, Yoshiyuki ^a   Funaki, Soichiro ^a   Nakagiri, Tomoyuki ^a   Shintani, Yasushi ^a   Inoue, Masayoshi ^a   Minami, Masato ^a   Okumura, Meinoshin ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoembryonic antigen; Computed tomography; Invasive adenocarcinoma; Non small cell lung cancer; Surgery; SUVmax

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; VERY ELDERLY;

CARCINOEMBRYONIC ANTIGEN; COMPUTED TOMOGRAPHY; INVASIVE ADENOCARCINOMA; NON-SMALL-CELL LUNG CANCER; SURGERY; SUVMAX;

ADENOCARCINOMA; ADULT; AGED; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892555268     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt329     Document Type: Article

References (18)

1. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M et al. Japanese Joint Committee for Lung Cancer Registration. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 2011;6:1229-35.
2. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-85.
3. International Union against CancerSobin LH, Gospodrowicz MK, Wittekind CH (eds). TNM Classification of Malignant Tumours. 7th edn. New York, NY: Wiley-Liss, 2009.
4. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009;253:606-22.
5. Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C et al. European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008;3:6-12.
6. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002;74: 174-9.
7. Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 2006;131:988-93.
8. Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64.
9. Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg 2011;141:1384-91.
10. Tsutani Y, Miyata Y, Yamanaka T, Nakayama H, Okumura S, Adachi S et al. Prognostic significance of using solid versus whole tumor size on highresolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study. J Thorac Cardiovasc Surg 2012;143:607-12.
11. Carrillo SA, Daniel VC, Hall N, Hitchcock CL, Ross P Jr, Kassis ES. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer. Ann Thorac Surg 2012;93:1621-4.
12. Huang TW, Hsieh CM, Chang H, Cheng YL, Tzao C, Huang WS et al. Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation. Eur J Cardiothorac Surg 2012;41:869-73.
13. Keyes JW Jr. SUV: standardized uptake or silly useless value? J Nucl Med 1995;36:1836-9.
14. Molina R, Auge JM, Escudero JM, Marrades R, Viñolas N, Carcereny E et al. 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE. Tumour Biol 2008;29:371-80.
15. Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T et al. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer 2004;101:803-9.
16. Van Schil PE, Asamura H, Rusch VW, Mitsudomi T, Tsuboi M, Brambilla E et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2012;39:478-86.
17. Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol 2012;19:661-8.
18. Kodama K, Higashiyama M, Takami K, Oda K, Okami J, Maeda J et al. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg 2008;34:1068-74.